ScholarWorks@Hanyang University

Browsing by Kim, Jeong-AAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 8 of 8

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

Park, Byeong-Bae; Kim, Won Seog; Suh, Cheolwon; Yoon, Dok Hyun; Won, Jong-Ho; Yang, Deok-Hwan; Do, Young-Rok; Lee, Won Sik; Kim, Jeong-A; Kim, Min Kyoung, et al.

ConferenceIssue Date2016Citation58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), pp.1823PublisherAMER SOC HEMATOLOGYPlaceUS; San Diego, CA
SCIESCOPUS
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)Go to Link

Park, Byeong-Bae; Kim, Won Seog; Suh, Cheolwon; Hong, Jung Yong; Yang, Deok-Hwan; Lee, Won Sik; Do, Young Rok; Koh, Young Il; Won, Jong-Ho; Kim, Min Kyoung, et al.

ArticleIssue Date2019CitationLEUKEMIA & LYMPHOMA, v.60, no.13, pp.3251 - 3257PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myelomaGo to Link

Kim, Min Kyoung; Kim, Kihyun; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung; Kim, Ki Hwan; Nam, Seung-Hyun; Mun, Yeung-Chul, et al.

ArticleIssue Date2017CitationOncotarget, v.8, no.23, pp 37605 - 37618PublisherImpact Journals
SCIESCOPUS
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trialsGo to Link

Shin, Dong-Yeop; Park, Sahee; Jang, Eunjung; Kong, Jee Hyun; Won, Young-Woong; Oh, Sukjoong; Choi, Yunsuk; Kim, Jeong-A; Lee, Se Won; Mun, Yeung-Chul, et al.

ArticleIssue Date2024CitationLeukemia Research, v.143, pp 1 - 7PublisherPergamon Press Ltd.
SCOPUSKCI
Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantationGo to Link

Lee, Hong Ghi; Kim, Sung-Yong; Kim, Inho; Kim, Yeo-Kyeoung; Kim, Jeong-A; Kim, Yang Soo; Lee, Ho Sup; Park, Jinny; Kim, Seok Jin; Shim, Hyeok, et al.

ArticleIssue Date2015CitationBlood Research, v.50, no.3, pp 160 - 166Publisher대한혈액학회
SCOPUSKCI
R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphomaGo to Link

Lee, Hong Ghi; Choi, Yunsuk; Kim, Sung-Yong; Kim, Inho; Kim, Yeo-Kyeoung; Kim, Yang Soo; Lee, Ho Sup; Kim, Seok Jin; Kim, Jeong-A; Park, Byeong-Bae, et al.

ArticleIssue Date2014CitationBlood Research, v.49, no.2, pp 107 - 114Publisher대한혈액학회
SCISCIESCOPUS
Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trialGo to Link

Park, Byeong-Bae; Kim, Won Seog; Suh, Cheolwon; Shin, Dong-Yeop; Kim, Jeong-A; Kim, Hoon-Gu; Lee, Won Sik

ArticleIssue Date2015CitationAnnals of Hematology, v.94, no.11, pp 1845 - 1851PublisherSpringer Verlag
SCIESCOPUS
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple MyelomaGo to Link

Lee, Gyeong-Won; Park, Sung Woo; Go, Se-Il; Kim, Hoon-Gu; Kim, Min Kyoung; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung, et al.

ArticleIssue Date2018CitationActa Haematologica, v.140, no.3, pp 146 - 156PublisherS. Karger AG
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어